Dravet Syndrome and Lennox-Gastaut Syndrome: Recent Treatment Advances
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
2
CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease
3
AES Presentations Highlight Zorevunersen as Disease-Modifying Treatment for Dravet Syndrome
4
Open Label Extension Confirms Cenobamate's Efficacy in Asian Populations
5
